StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IBAT

International Battery Metals Ltd.

IBATF OTC Mining & Quarrying of Nonmetallic Minerals (No Fuels) EDGAR ↗
$0.07
-0.00 -1.52%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$24.6M
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
$122K
EPS (TTM) ⓘ
$0.00
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
-$10.1M
Cash ⓘ
$9.44M
Total assets ⓘ
$39.2M
Gross margin ⓘ
—
52-week range ⓘ
$0.06 – $0.31

AI briefing

from the latest 10-K, 10-Q and 8-K events

Pre-revenue developer of modular direct lithium extraction (DLE) plants that is testing brines and marketing its technology to brine resource owners.

What they do

International Battery Metals Ltd. is an advanced technology and manufacturing company focused on its proprietary and patented modular direct lithium extraction (MDLE) plants, which extract lithium chloride from brine at sufficient concentration and purity to allow production of lithium carbonate for batteries. The MDLE plant is modular, so it can be deployed and redeployed at a different brine deposit once a resource is spent, and scalable, so valves, pumps, proprietary columns and media can be configured to customer needs and multiple plants linked. The proprietary absorption extraction process is designed to be environmentally responsible and low-cost, re-injecting spent brine into the aquifer after extraction. The company is headquartered in Houston, Texas and has not yet delivered MDLE plants or licensed its technology to customers.

Revenue drivers

  • Brine testing services — The only revenue generated today comes from testing brine content of potential customers; first quarter fiscal 2027 revenue was $120 thousand versus $7 thousand a year earlier.
  • Technology licensing agreements — Future revenue is anticipated from technology licensing agreements, though none have been signed; the company states it is pre-revenue with no MDLE Plants delivered or technology licensed.
  • MDLE plant construction and sale — Anticipated future revenue includes constructing MDLE plants and selling them with an associated technology licensing agreement, as well as equipment rentals.
  • Offtake, joint ventures and management fees — Anticipated future revenue also includes participation in joint ventures or special purpose entities with resource developers and management fees for overseeing construction and development of future lithium extraction facilities.

Recent performance

For the first quarter of fiscal 2027 ended June 30, 2026, revenue was $120 thousand compared to $7 thousand in the prior-year period, reflecting service revenue from brine testing activities. Operating loss was $2.9 million compared to $3.6 million a year earlier, with operating costs excluding depreciation of $0.4 million versus $0.6 million and SG&A excluding depreciation of $1.8 million versus $2.3 million. A $2.9 million gain from the change in fair value of the warrant liability (versus a $5.3 million gain in the prior year) narrowed the net loss to $28 thousand, or $0.00 basic and diluted EPS, compared with net income of $1.7 million, or $0.01, a year earlier. Full-year fiscal 2026 net income was $122 thousand versus a $3.5 million net loss in fiscal 2025, while operating cash flow remained negative at negative $9.7 million in fiscal 2026 versus negative $13.5 million in fiscal 2025. At June 30, 2026, total assets were $39.2 million, total liabilities $10.6 million, shareholders' equity $28.6 million and cash $9.4 million.

Strategy

Management's stated focus is taking its technology from the lab to the field, deploying the existing Initial MDLE Plant and building on proprietary DLE technology developed by Dr. Burba to develop and deploy additional MDLE plants. The company is actively marketing its Initial MDLE Plant and technology to US owners of brine reservoirs, particularly in the Smackover formation in Arkansas and Texas, where it believes owners are best positioned to benefit from the existing plant. It estimates it would need to spend approximately $2.0 million to $12.0 million to customize the Initial MDLE Plant for an initial customer depending on the reservoir's lithium concentration and purity. It is also in preliminary research and development of the next generation of MDLE technology, having purchased two larger diameter columns, with estimated costs of approximately $500,000 for instrumentation and engineering and an additional $250,000 for construction and testing of the larger columns. The interim CEO cited active pursuit of opportunities in the Smackover, the Middle East and Argentina, alongside continuous brine testing and technical evaluation with prospective customers in those regions.

Risks

  • Pre-revenue and history of losses — The company states it is a pre-revenue, development-stage company with a limited operating history, a history of losses, and substantial doubt about its ability to achieve profitability, with no MDLE Plants delivered or technology licensed.
  • Need for substantial additional capital — The company states it will require substantial additional capital and that such financing may not be available on acceptable terms or at all, against a $9.4 million cash balance at June 30, 2026 and negative operating cash flow of $9.7 million in fiscal 2026.
  • Commercialization and customer conversion risk — Success depends on continued research and development, successful customization and deployment of the MDLE Plant, demonstration of commercial viability, and conversion of testing, pilot work and business development into revenue-generating contracts, which has not yet occurred.
  • Competition and lithium market sensitivity — The company states it operates in a highly competitive market against other direct lithium extraction technologies and traditional lithium extraction methods, many with greater resources, and that its prospects are highly sensitive to lithium demand, lithium prices, EV and battery storage adoption, government incentives and competing battery technologies.

Outlook

Management says its focus is the next step of putting the technology into the field, and that it is actively pursuing opportunities in the Smackover, the Middle East and Argentina. The company continues brine testing and technical evaluation with prospective customers in the United States, the Middle East and Argentina and is positioning its modular DLE technology as a scalable component within a broader lithium production flowsheet. It also states it has implemented a disciplined cost structure while prioritizing customer engagement and proposal development. No specific revenue, earnings or contract guidance was provided in the excerpts.

Recent SEC filings

40 most recent
Annual, quarterly & current reports
Other filings
SCHEDULE 13G May 15, 2026
SCHEDULE 13D/A Apr 30, 2026
SCHEDULE 13D/A Feb 25, 2026
SCHEDULE 13D/A Feb 25, 2026
SCHEDULE 13D Feb 6, 2026